Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 1Mesothelioma, Malignant 1Lung Neoplasms 1Leukemia 1Congenital Abnormalities 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 2Azacitidine 2sargramostim 1pemigatinib 1pembrolizumab 1motexafin gadolinium 1incomplete Freund's adjuvant 1cc-486 1Trastuzumab 1Tinzaparin 1Quality of Life 1Polymerase Chain Reaction 1Patient Reported Outcome Measures 1Panitumumab 1Molecular Diagnostic Techniques 1Injections 1Immunotherapy 1Immunoenzyme Techniques 1Imatinib Mesylate 1IFL protocol 1Flow Cytometry 1Epoetin Alfa 1Drug Therapy 1Doxorubicin 1Docetaxel 1Cisplatin 1Cetuximab 1Biological Therapy 1Antineoplastic Protocols 14-phenylbutyric acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × incomplete Freund's adjuvant × Myeloid × Clear all
NCT00398138 2016-03-02

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
22 enrolled 7 charts
MyeloidOther hematologic neoplasmOther solid neoplasmThoracic

Congenital Abnormalities, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Leukemia, Lung Neoplasms, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡